Form 4 for CYTK CYTOKINETICS INC
Accepted 2025-05-14 00:00:00 ET · period of report 2025-05-14 · accession 0001127602-25-014354 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-05-14 | 2025-05-14 | CYTK | Wysenski Nancy | Dir | A - Grant | $0.00 | +7,333 | 30.6K | +32% | $0 |
| D | 2025-05-14 | 2025-05-14 | CYTK | Wysenski Nancy | Dir | A - Grant | $0.00 | +10.9K | 10.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-14 | A | A | 7,333 | $0.00 | 30,610 | D | — | — | |
| 2 | Derivative | Non-Qualified Stock Option (Right to Buy) | 2025-05-14 | A | A | 10,880 | $0.00 | 10,880 | D | $30.00 · 2025-06-16 to 2035-05-13 | 10,880 Common Stock |